Related Experiment Video
Updated: Jul 19, 2026

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management
Dimitrios P Kontoyiannis1, Russell E Lewis
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. dkontoyi@mdanderson.org
Abstract:
Zygomycosis is an increasingly common infection in immunocompromised patients. Advances in the understanding of Zygomycetes pathobiology and the introduction of new drugs with improved activity and tolerability for treatment of zygomycosis have improved the prospects of effectively controlling this devastating infection. Further reductions in mortality will require improved diagnostic and novel therapeutic approaches for this group of aggressive opportunistic molds.
Insights
Zygomycosis infections are rising in immunocompromised individuals. New treatments offer hope, but improved diagnostics and therapies are crucial for reducing mortality from these aggressive molds.
Area of Science:
- Mycology
- Infectious Diseases
- Immunocompromised Host Research
Background:
- Zygomycosis is a serious fungal infection with increasing prevalence.
- Immunocompromised patients are particularly susceptible to Zygomycosis.
- Advances in understanding Zygomycetes pathobiology are crucial.
Purpose of the Study:
- To review current understanding and treatment of Zygomycosis.
- To highlight the impact of new antifungal drugs.
- To identify needs for improved diagnostics and therapeutics.
Main Methods:
- Literature review of Zygomycosis research.
- Analysis of new drug efficacy and tolerability.
- Assessment of current diagnostic methods.
Main Results:
- New antifungal agents show improved activity and tolerability.
- Understanding of Zygomycetes pathobiology has advanced.
- Zygomycosis remains a devastating infection with significant mortality.
Conclusions:
- Effective control of Zygomycosis has improved but requires further advances.
- Novel diagnostic and therapeutic strategies are essential.
- Reducing mortality necessitates addressing aggressive opportunistic molds.
Related Concept Videos
Fungal Group Zygomycota
Cryptococcal Meningitis
Antifungal Agents
Candidiasis
Endocarditis III: Medical Management
Fungal Phylum Microsporidia
